PODNL1 and cancer: Analysis of clinical stages in pan-cancer presented the results that the expression levels of PODNL1 increased with tumor development as its expression levels differed significantly between early (I and II) and advanced (III and IV) stages in multiple cancers (Figure 2D,E).